NXP Semiconductors N.V.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), NXP Semiconductors N.V. reported revenue of $12.3B (-2.7% year on year) and net income of $2.1B (-18.6% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenue | $12.3B | $12.6B | $13.3B | $13.2B |
| Cost of revenue | ($5.6B) | ($5.5B) | ($5.7B) | ($5.7B) |
| Gross profit | $6.7B | $7.1B | $7.6B | $7.5B |
| Research and development | ($2.4B) | ($2.3B) | ($2.4B) | ($2.1B) |
| Selling, general and administrative | ($1.2B) | ($1.2B) | ($1.2B) | ($1.1B) |
| Amortization of acquisition-related intangible assets | ($117.0M) | ($136.0M) | ($300.0M) | ($509.0M) |
| Total operating expenses | ($3.7B) | ($3.6B) | ($3.9B) | ($3.7B) |
| Other income (expense) | $12.0M | ($55.0M) | ($15.0M) | $3.0M |
| Operating income (loss) | $3.0B | $3.4B | $3.7B | $3.8B |
| Other financial income (expense) | ($384.0M) | ($318.0M) | ($309.0M) | ($416.0M) |
| Income (loss) before income taxes | $2.7B | $3.1B | $3.4B | $3.4B |
| Benefit (provision) for income taxes | ($525.0M) | ($545.0M) | ($523.0M) | ($529.0M) |
| Results relating to equity-accounted investees | ($70.0M) | ($12.0M) | ($7.0M) | ($1.0M) |
| Net income (loss) | $2.1B | $2.5B | $2.8B | $2.8B |
| Less: Net income (loss) attributable to non-controlling interests | $47.0M | $32.0M | $25.0M | $46.0M |
| Net income (loss) attributable to stockholders | $2.0B | $2.5B | $2.8B | $2.8B |
| Basic (in dollars per share) | $8.00 | $9.84 | $10.83 | $10.64 |
| Diluted (in dollars per share) | $7.95 | $9.73 | $10.70 | $10.55 |
| Basic (in shares) | 252.7M | 255.2M | 258.4M | 261.9M |
| Diluted (in shares) | 254.3M | 257.8M | 261.4M | 264.1M |
| Line item | Jun 28, 2026 · Q2 | Mar 29, 2026 · Q1 | Sep 28, 2025 · Q3 | Jun 29, 2025 · Q2 |
|---|---|---|---|---|
| Revenue | $3.5B | $3.2B | $3.2B | $2.9B |
| Cost of revenue | ($1.5B) | ($1.4B) | ($1.4B) | ($1.4B) |
| Gross profit | $2.0B | $1.8B | $1.8B | $1.6B |
| Research and development | ($604.0M) | ($588.0M) | ($575.0M) | ($573.0M) |
| Selling, general and administrative | ($291.0M) | ($284.0M) | ($286.0M) | ($278.0M) |
| Amortization of acquisition-related intangible assets | ($31.0M) | ($32.0M) | ($31.0M) | ($25.0M) |
| Total operating expenses | ($926.0M) | ($904.0M) | ($892.0M) | ($876.0M) |
| Other income (expense) | ($5.0M) | $621.0M | ($2.0M) | $1.0M |
| Operating income (loss) | $1.1B | $1.5B | $893.0M | $687.0M |
| Other financial income (expense) | ($97.0M) | ($96.0M) | ($98.0M) | ($86.0M) |
| Income (loss) before income taxes | $974.0M | $1.4B | $795.0M | $601.0M |
| Benefit (provision) for income taxes | ($189.0M) | ($272.0M) | ($148.0M) | ($116.0M) |
| Results relating to equity-accounted investees | ($3.0M) | ($4.0M) | ($1.0M) | ($28.0M) |
| Net income (loss) | $782.0M | $1.1B | $646.0M | $457.0M |
| Less: Net income (loss) attributable to non-controlling interests | $15.0M | $11.0M | $15.0M | $12.0M |
| Net income (loss) attributable to stockholders | $767.0M | $1.1B | $631.0M | $445.0M |
| Basic net income (loss) (in dollars per share) | $3.04 | $4.44 | $2.50 | $1.76 |
| Diluted net income (loss) (in dollars per share) | $3.02 | $4.43 | $2.48 | $1.75 |
| Basic (in shares) | 252.4M | 252.7M | 252.2M | 252.4M |
| Diluted (in shares) | 254.0M | 253.5M | 254.3M | 253.8M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $3.3B | $3.3B | $3.9B | $3.8B |
| Accounts receivables, net | $1.1B | $1.0B | $894.0M | $960.0M |
| Asset, held-for-sale, current | $372.0M | — | — | — |
| Inventories, net | $2.6B | $2.4B | $2.1B | $1.8B |
| Other current assets | $669.0M | $625.0M | $565.0M | $348.0M |
| Total current assets | $7.9B | $7.3B | $7.9B | $6.9B |
| Deferred tax assets within non-current assets | $1.2B | $1.3B | — | — |
| Other non-current assets | $2.6B | $1.8B | $2.3B | $1.9B |
| Property, plant and equipment, net | $3.0B | $3.3B | $3.3B | $3.1B |
| Identified intangible assets, net | $1.5B | $836.0M | $922.0M | $1.3B |
| Goodwill | $10.3B | $9.9B | $10.0B | $9.9B |
| Total non-current assets | $18.6B | $17.1B | $16.5B | $16.3B |
| Total assets | $26.6B | $24.4B | $24.4B | $23.2B |
| Accounts payable | $997.0M | $1.0B | $1.2B | $1.6B |
| Restructuring liabilities | $189.0M | $147.0M | $92.0M | $19.0M |
| Other current liabilities | $1.4B | $1.4B | $1.9B | $1.6B |
| Short-term debt | $1.3B | $500.0M | $1.0B | — |
| Total current liabilities | $3.9B | $3.1B | $4.1B | $3.3B |
| Long-term debt | $11.0B | $10.4B | $10.2B | $11.2B |
| Restructuring liabilities - noncurrent | $81.0M | $10.0M | $9.0M | $1.0M |
| Other non-current liabilities | $1.2B | $1.4B | $1.1B | $1.0B |
| Total non-current liabilities | $12.2B | $11.8B | $11.3B | $12.2B |
| Non-controlling interests | $395.0M | $348.0M | $316.0M | $291.0M |
| Common stock, par value €0.20 per share:, Authorized 430,503,000 shares (2018: 430,503,000 shares) Issued and fully paid: 315,519,638 shares (2018: 328,702,719 shares) | $56000000.00 | $56000000.00 | $56000000.00 | $56000000.00 |
| Capital in excess of par value | $15.4B | $15.0B | $14.5B | $14.1B |
| Treasury shares, at cost: 21,664,934 shares (2024: 20,195,011 shares) | -4.3B | -4.0B | -3.2B | — |
| Accumulated other comprehensive income (loss) | $213.0M | ($17.0M) | $90.0M | $76.0M |
| Accumulated deficit | ($1.4B) | ($1.8B) | ($2.8B) | ($4.0B) |
| Total Stockholders’ equity | $10.1B | $9.2B | $8.6B | $7.4B |
| Total equity | $10.5B | $9.5B | $9.0B | $7.7B |
| Total liabilities and equity | $26.6B | $24.4B | $24.4B | $23.2B |
| Preferred stock, par value per share (in euros per share) | $0.20 | $0.20 | — | $0.20 |
| Preferred stock, authorized shares (in shares) | 645.8M | 645.8M | — | 645.8M |
| Preferred stock, issued (in shares) | 0 | 0 | — | 0 |
| Common Stock, Par or Stated Value Per Share | $0.20 | $0.20 | — | $0.20 |
| Common Stock, authorized shares (in shares) | 430.5M | 430.5M | — | 430.5M |
| Common stock, issued and fully paid (in shares) | 274.5M | 274.5M | — | 274.5M |
| Treasury shares (in shares) | 21.7M | 20.2M | — | 15.1M |
| Line item | Jun 28, 2026 | Mar 29, 2026 | Sep 28, 2025 | Jun 29, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $3.2B | $3.7B | $3.5B | $3.2B |
| Accounts receivable, net | $1.3B | $1.2B | $1.1B | $1.1B |
| Assets held for sale | $92.0M | $91.0M | $292.0M | $294.0M |
| Inventories, net | $2.6B | $2.5B | $2.5B | $2.4B |
| Other current assets | $539.0M | $644.0M | $716.0M | $790.0M |
| Total current assets | $7.7B | $8.2B | $8.5B | $7.7B |
| Deferred tax assets | $1.2B | $1.2B | $1.3B | $1.3B |
| Other non-current assets | $3.2B | $3.0B | $2.2B | $1.9B |
| Property, plant and equipment, net of accumulated depreciation of $6,553 and $6,366 respectively | $2.8B | $2.9B | $3.1B | $3.1B |
| Identified intangible assets, net of accumulated amortization of $812 and $820 respectively | $1.4B | $1.5B | $1.1B | $1.1B |
| Goodwill | $10.3B | $10.3B | $10.1B | $10.1B |
| Total non-current assets | $19.0B | $19.0B | $17.8B | $17.6B |
| Total assets | $26.7B | $27.1B | $26.4B | $25.3B |
| Accounts payable | $984.0M | $904.0M | $886.0M | $892.0M |
| Restructuring liabilities-current | $111.0M | $133.0M | $49.0M | $65.0M |
| Other current liabilities | $1.7B | $1.9B | $1.4B | $1.5B |
| Short-term debt | $999.0M | $750.0M | $1.3B | $2.0B |
| Total current liabilities | $3.8B | $3.6B | $3.6B | $4.4B |
| Long-term debt | $10.0B | $11.0B | $11.0B | $9.5B |
| Restructuring liabilities | $65.0M | $76.0M | $60.0M | $60.0M |
| Other non-current liabilities | $1.1B | $1.2B | $1.3B | $1.3B |
| Total non-current liabilities | $11.1B | $12.2B | $12.3B | $10.9B |
| Total liabilities | $14.9B | $15.8B | $15.9B | $15.3B |
| Non-controlling interests | $362.0M | $347.0M | $382.0M | $367.0M |
| Common stock, par value €0.20 per share: | $56000000.00 | $56000000.00 | $56000000.00 | $56000000.00 |
| Capital in excess of par value | $15.6B | $15.5B | $15.3B | $15.2B |
| Treasury shares, at cost: | -4.4B | -4.3B | -4.4B | -4.4B |
| Accumulated other comprehensive income (loss) | $134.0M | $171.0M | $167.0M | $170.0M |
| Accumulated deficit | $10.0M | ($496.0M) | ($1.1B) | ($1.4B) |
| Total stockholders’ equity | $11.4B | $10.9B | $10.0B | $9.6B |
| Total equity | $11.8B | $11.3B | $10.4B | $9.9B |
| Total liabilities and equity | $26.7B | $27.1B | $26.4B | $25.3B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $2.1B | $2.5B | $2.8B | $2.8B |
| Depreciation, amortization and impairment | $832.0M | $925.0M | $1.1B | — |
| Share-based compensation | $462.0M | $461.0M | $411.0M | $364.0M |
| Amortization of discount (premium) on debt, net | $3.0M | $3.0M | $2.0M | $2.0M |
| Amortization of debt issuance costs | $7.0M | $7.0M | $8.0M | $7.0M |
| Net (gain) loss on sale of assets | ($29.0M) | ($3.0M) | ($1.0M) | $0 |
| Results relating to equity-accounted investees | $70.0M | $12.0M | $7.0M | $1.0M |
| (Gain) loss on equity securities, net | $2.0M | $18.0M | ($1.0M) | $4.0M |
| Deferred tax expense (benefit) | ($8.0M) | ($272.0M) | ($267.0M) | ($236.0M) |
| (Increase) decrease in receivables and other current assets | ($43.0M) | ($207.0M) | ($138.0M) | ($106.0M) |
| (Increase) decrease in inventories | ($308.0M) | ($222.0M) | ($353.0M) | ($593.0M) |
| Increase (decrease) in accounts payable and accrued liabilities | ($50.0M) | ($188.0M) | ($119.0M) | $633.0M |
| Decrease (increase) in other non-current assets | ($212.0M) | ($306.0M) | $16.0M | ($306.0M) |
| Exchange differences | $24.0M | $14.0M | $22.0M | $17.0M |
| Other items | $2.0M | ($2.0M) | ($2.0M) | $7.0M |
| Net cash provided by (used for) operating activities | $2.8B | $2.8B | $3.5B | $3.9B |
| Purchase of identified intangible assets | ($140.0M) | ($149.0M) | ($179.0M) | ($159.0M) |
| Capital expenditures on property, plant and equipment | ($397.0M) | ($727.0M) | ($827.0M) | ($1.1B) |
| Insurance recoveries received for equipment damage | $0 | $2.0M | $0 | $0 |
| Proceeds from disposals of property, plant and equipment | $2.0M | $4.0M | $1.0M | $2.0M |
| Advance payment from sale of property, plant and equipment | $0 | $30.0M | — | — |
| Purchase of interests in businesses, net of cash acquired | ($1.2B) | $0 | $0 | ($27.0M) |
| Payments to Acquire Short-Term Investments | ($500.0M) | $0 | — | — |
| Proceeds from Sale of Short-Term Investments | $500.0M | $409.0M | — | — |
| Purchase of investments | ($649.0M) | ($260.0M) | ($94.0M) | ($20.0M) |
| Proceeds from the sale of investments | $2.0M | $5.0M | $0 | $13.0M |
| Net cash provided by (used for) investing activities | ($2.4B) | ($686.0M) | ($1.5B) | ($1.2B) |
| Repurchase of long-term debt | ($500.0M) | ($1.0B) | $0 | ($917.0M) |
| Proceeds from the issuance of long-term debt | $1.9B | $670.0M | $0 | $1.5B |
| Cash paid for debt issuance costs | ($8.0M) | ($1.0M) | $0 | ($14.0M) |
| Proceeds from the issuance of commercial paper notes | $2.4B | — | — | — |
| Repayment of commercial paper notes | ($2.4B) | — | — | — |
| Dividends paid to common stockholders | ($1.0B) | ($1.0B) | ($1.0B) | ($815.0M) |
| Proceeds from issuance of common stock through stock plans | $83.0M | $82.0M | $71.0M | $59.0M |
| Purchase of treasury shares and restricted stock unit withholdings | -899.0M | -1.4B | -1.1B | -1.4B |
| Other, net | ($13.0M) | ($2.0M) | ($2.0M) | ($2.0M) |
| Net cash provided by (used for) financing activities | ($494.0M) | ($2.7B) | ($2.0B) | ($1.6B) |
| Effect of changes in exchange rates on cash positions | $6.0M | ($4.0M) | $2.0M | ($12.0M) |
| Increase (decrease) in cash and cash equivalents | ($25.0M) | ($570.0M) | $17.0M | $1.0B |
| Cash and cash equivalents at beginning of period | $3.3B | $3.9B | $3.8B | $2.8B |
| Cash and cash equivalents at end of period | $3.3B | $3.3B | $3.9B | $3.8B |
| Interest | $306.0M | $243.0M | $261.0M | $323.0M |
| Income taxes, net of refunds | $581.0M | $867.0M | $919.0M | $558.0M |
| Cash proceeds from the sale of assets | $38.0M | $4.0M | $1.0M | $2.0M |
| Book value of these assets | ($9.0M) | ($1.0M) | $0 | ($2.0M) |
| Line item | Jun 28, 2026 · YTD | Mar 29, 2026 · Q1 | Sep 28, 2025 · YTD | Jun 29, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $1.9B | $1.1B | $1.6B | $954.0M |
| Depreciation and amortization | $363.0M | $179.0M | $617.0M | $416.0M |
| Share-based compensation | $214.0M | $109.0M | $362.0M | $244.0M |
| Amortization of discount (premium) on debt, net | $1.0M | $1.0M | $2.0M | $1.0M |
| Amortization of debt issuance costs | $4.0M | $2.0M | $5.0M | $3.0M |
| Net (gain) loss on sale of assets | ($627.0M) | ($627.0M) | ($29.0M) | ($28.0M) |
| (Gain) loss on equity security, net | $0 | ($1.0M) | $2.0M | $3.0M |
| Results relating to equity-accounted investees | $7.0M | $4.0M | $33.0M | $32.0M |
| Deferred tax expense (benefit) | ($41.0M) | ($28.0M) | ($32.0M) | ($24.0M) |
| (Increase) decrease in receivables and other current assets | ($101.0M) | ($115.0M) | ($81.0M) | ($135.0M) |
| (Increase) decrease in inventories | $53.0M | $87.0M | ($180.0M) | ($84.0M) |
| Increase (decrease) in accounts payable and other liabilities | $95.0M | $231.0M | ($296.0M) | ($77.0M) |
| Decrease (increase) in other non-current assets | ($230.0M) | ($182.0M) | ($98.0M) | $25.0M |
| Exchange differences | $7.0M | $4.0M | $21.0M | $13.0M |
| Other items | ($7.0M) | ($4.0M) | $3.0M | $1.0M |
| Net cash provided by (used for) operating activities | $1.7B | $793.0M | $1.9B | $1.3B |
| Purchase of identified intangible assets | ($79.0M) | ($42.0M) | ($85.0M) | ($62.0M) |
| Capital expenditures on property, plant and equipment | ($148.0M) | ($79.0M) | ($299.0M) | ($222.0M) |
| Purchase of interests in businesses, net of cash acquired | $0 | — | ($690.0M) | ($679.0M) |
| Proceeds from disposals of property, plant and equipment | $0 | $0 | $2.0M | $1.0M |
| Proceeds from sale of interests in businesses, net of cash divested | $878.0M | $878.0M | — | — |
| Purchase of investments | ($381.0M) | ($249.0M) | ($319.0M) | ($146.0M) |
| Proceeds from sale of investments | $1.0M | — | $0 | $0 |
| Net cash provided by (used for) investing activities | $271.0M | $508.0M | ($1.9B) | ($1.1B) |
| Repurchase of long-term debt | ($1.3B) | ($501.0M) | ($500.0M) | ($500.0M) |
| Proceeds from the issuance of long-term debt | $0 | $0 | $1.9B | $370.0M |
| Cash paid for debt issuance costs | ($3.0M) | ($3.0M) | ($8.0M) | — |
| Proceeds from issuance of commercial paper notes | $0 | $0 | $2.4B | $2.2B |
| Repayment of commercial paper notes | $0 | $0 | ($2.4B) | ($1.5B) |
| Dividends paid to non-controlling interests | ($29.0M) | ($29.0M) | — | — |
| Dividends paid to common stockholders | ($512.0M) | ($256.0M) | ($771.0M) | ($515.0M) |
| Proceeds from issuance of common stock through stock plans | $37.0M | $36.0M | $77.0M | $39.0M |
| Purchase of treasury shares and restricted stock unit withholdings | -206.0M | -102.0M | -561.0M | -507.0M |
| Other, net | ($1.0M) | ($1.0M) | ($2.0M) | ($1.0M) |
| Net cash provided by (used for) financing activities | ($2.0B) | ($856.0M) | $118.0M | ($364.0M) |
| Effect of changes in exchange rates on cash positions | ($4.0M) | ($4.0M) | $6.0M | $6.0M |
| Increase (decrease) in cash and cash equivalents | ($45.0M) | $441.0M | $162.0M | ($122.0M) |
| Cash and cash equivalents at beginning of period | $3.3B | $3.3B | $3.3B | $3.3B |
| Cash and cash equivalents at end of period | $3.2B | $3.7B | $3.5B | $3.2B |
| Interest | $175.0M | $79.0M | $194.0M | $150.0M |
| Income taxes, net of refunds | $382.0M | $93.0M | $437.0M | $263.0M |
| Cash proceeds from the sale of assets | $878.0M | $878.0M | $38.0M | $37.0M |
| Non-cash consideration | $44.0M | $44.0M | — | — |
| Book value of these assets and transaction costs | ($295.0M) | ($295.0M) | ($9.0M) | — |
| Non-cash capital expenditures | $64.0M | $87.0M | $112.0M | $103.0M |
NXP Semiconductors N.V. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.